Basso Stephen 4
4 · Inozyme Pharma, Inc. · Filed Jul 24, 2020
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2020-07-23+27,433→ 27,433 totalExercise: $16.00Exp: 2030-07-22→ Common Stock (27,433 underlying)
Footnotes (1)
- [F1]The option was granted on July 23, 2020. The shares underlying the option are scheduled to vest in equal monthly installments from July 23, 2020 through July 23, 2024.